(Q29012337)

20 September 2017

1 reference

title

Combination Antiretroviral Therapy (English)

1 reference

23 March 2017

Combination antiretroviral therapy. Back to the future (English)

1 reference

20 September 2017

main subject

anti-retroviral agent

0 references

author name string

Joep Lange

series ordinal

1

1 reference

23 March 2017

Lange J

series ordinal

1

1 reference

20 September 2017

publication date

1995

1 reference

23 March 2017

1 January 1995

1 reference

20 September 2017

2 references

23 March 2017

20 September 2017

volume

49

1 reference

23 March 2017

49 Suppl 1

1 reference

20 September 2017

issue

Supplement 1

1 reference

23 March 2017

page(s)

32-37

1 reference

23 March 2017

32-7; discussion 38-40

1 reference

A comparative trial of didanosine or zalcitabine after treatment with zidovudine in patients with human immunodeficiency virus infection. The Terry Beirn Community Programs for Clinical Research on AIDS.

20 September 2017

cites work

1 reference

12 December 2020

Combination therapy with zidovudine and dideoxycytidine in patients with advanced human immunodeficiency virus infection. A phase I/II study

1 reference

12 December 2020

Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases

1 reference

12 December 2020

Zidovudine twice daily in asymptomatic subjects with HIV infection and a high risk of progression to AIDS: a randomized, double-blind placebo-controlled study. The European-Australian Collaborative Group (Study 017)

1 reference

12 December 2020

The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group

1 reference

12 December 2020

A controlled trial comparing continued zidovudine with didanosine in human immunodeficiency virus infection. The NIAID AIDS Clinical Trials Group

1 reference

12 December 2020

A randomized pilot study of alternating or simultaneous zidovudine and didanosine therapy in patients with symptomatic human immunodeficiency virus infection

1 reference

12 December 2020

Zidovudine in persons with asymptomatic HIV infection and CD4+ cell counts greater than 400 per cubic millimeter. The European-Australian Collaborative Group

1 reference

12 December 2020

Quality of life in a placebo-controlled trial of zidovudine in patients with AIDS and AIDS-related complex

1 reference

12 December 2020

AIDS dementia complex and didanosine

1 reference

12 December 2020

Effect of zidovudine and Pneumocystis carinii pneumonia prophylaxis on progression of HIV-1 infection to AIDS

1 reference

12 December 2020

The effects on survival of early treatment of human immunodeficiency virus infection

1 reference

12 December 2020

Declining incidence of AIDS dementia complex after introduction of zidovudine treatment

1 reference

12 December 2020

Evaluation of the quality of life associated with zidovudine treatment in asymptomatic human immunodeficiency virus infection. The AIDS Clinical Trials Group

1 reference

12 December 2020

Combination and monotherapy with zidovudine and zalcitabine in patients with advanced HIV disease. The NIAID AIDS Clinical Trials Group

1 reference

12 December 2020

Concorde: MRC/ANRS randomised double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection. Concorde Coordinating Committee

1 reference

12 December 2020

The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

1 reference

12 December 2020

A controlled trial of early versus late treatment with zidovudine in symptomatic human immunodeficiency virus infection. Results of the Veterans Affairs Cooperative Study

1 reference

12 December 2020

Three-drug synergistic inhibition of HIV-1 replication in vitro by zidovudine, recombinant soluble CD4, and recombinant interferon-alpha A

1 reference

12 December 2020

Combination therapy with zidovudine and didanosine compared with zidovudine alone in HIV-1 infection

1 reference

12 December 2020

Strategies for antiviral therapy in AIDS.

1 reference

12 December 2020

Factors influencing survival after AIDS: report from the Multicenter AIDS Cohort Study (MACS).

1 reference

12 December 2020

Presentation and course of AIDS dementia complex: 10 years of follow-up in Amsterdam, The Netherlands

1 reference

12 December 2020

Effect of stage of disease and drug dose on zidovudine susceptibilities of isolates of human immunodeficiency virus

1 reference

12 December 2020

Zidovudine compared with didanosine in patients with advanced HIV type 1 infection and little or no previous experience with zidovudine. AIDS Clinical Trials Group

1 reference

12 December 2020

Prolonged zidovudine therapy in patients with AIDS and advanced AIDS-related complex. AZT Collaborative Working Group

1 reference

12 December 2020

10.2165/00003495-199500491-00008

Identifiers

DOI

1 reference

Dimensions Publication ID

23 March 2017

1039359048

0 references

1 reference